Drug Shortage Report for TEMPRA DOUBLE STRENGTH CHILDREN'S SYRUP
| Report ID | 187735 |
| Drug Identification Number | 00875996 |
| Brand name | TEMPRA DOUBLE STRENGTH CHILDREN'S SYRUP |
| Common or Proper name | ACETAMINOPHEN |
| Company Name | PALADIN LABS INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | ACETAMINOPHEN |
| Strength(s) | 160MG |
| Dosage form(s) | SYRUP |
| Route of administration | ORAL ORAL |
| Packaging size | 100mL |
| ATC code | N02BE |
| ATC description | OTHER ANALGESICS AND ANTIPYRETICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2022-03-17 |
| Actual start date | 2022-03-17 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2023-03-23 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 100 BLVD ALEXIS-NIHON, SUITE 600 SAINT-LAURENT, QUEBEC CANADA H4M 2P2 |
| Company contact information | 1-866-340-1112 paladincs@endo.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2023-03-23 | French | Compare |
| v1 | 2023-03-23 | English | Compare |
Showing 1 to 2 of 2